AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 542.53M
Enterprise Value 345.42M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)150.11
Price/Book (mrq)N/A
Enterprise Value/Revenue 3160.29
Enterprise Value/EBITDA 6-7.83

Trading Information

Stock Price History

Beta (3Y Monthly) -4.18
52-Week Change 3-73.20%
S&P500 52-Week Change 31.52%
52 Week High 32.5200
52 Week Low 30.4600
50-Day Moving Average 30.7511
200-Day Moving Average 31.1808

Share Statistics

Avg Vol (3 month) 371.93k
Avg Vol (10 day) 386.2k
Shares Outstanding 561.57M
Float 15.68M
% Held by Insiders 170.54%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-2,048.01%

Management Effectiveness

Return on Assets (ttm)-203.29%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)283.34k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)1,038.80%
Gross Profit (ttm)187.1k
Net Income Avi to Common (ttm)-6.46M
Diluted EPS (ttm)-0.1080
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.52M
Total Cash Per Share (mrq)0.04
Total Debt (mrq)6.04M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.69
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-3.97M
Levered Free Cash Flow (ttm)-1.44M